cdmo.directory
← Compare landing

WuXi Advanced Therapies vs ProBio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/advancedtherapies/probio

CategoryWuXi Advanced TherapiesProBio
Listed sitecdmoboth
SummaryCell & gene therapy CDMO offering discovery, process development, analytical development, cell banking, clinical and commercial manufacturing, plus biosafety testing for biologics, mAbs, vaccines, and CGT developers.ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell-Line Development
  • Technology Transfer
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Vaccine Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • In Vitro Pharmacology
  • Protein Engineering
  • Bioanalysis
  • Flow Cytometry Services
  • Immunogenicity Assays (ADA / NAb)
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Infectious Disease
Locations
  • Headquarters, Philadelphia, PA, United States
  • Philadelphia, Philadelphia, PA, United States
  • Allendale, Allendale, NJ, United States
  • Taufkirchen, Taufkirchen, Bavaria, Germany
  • London, London, England, United Kingdom
  • Yokohama, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Philadelphia, PA, United States
  • Manufacturing, Allendale, NJ, United States
  • Manufacturing, Taufkirchen, Bavaria, Germany
  • Office, London, England, United Kingdom
  • Manufacturing, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Allendale, NJ, United States
  • Manufacturing & Testing, Taufkirchen, Bavaria, Germany
  • Manufacturing & Testing, Yokohama, Kanagawa, Japan
  • United States, United States
  • Netherlands, Netherlands
  • South Korea, South Korea
  • Hong Kong, Hong Kong, China
  • Shanghai, Shanghai, China
  • Nanjing, Nanjing, China
Certifications
  • FDA · Identifier: Commercial manufacturing approval
  • EMA · Identifier: Commercial manufacturing approval
  • PMDA · Identifier: Commercial manufacturing approval
  • FDA · Identifier: FDA approval for commercial manufacturing
  • EMA · Identifier: EMA approval for commercial manufacturing
  • PMDA · Identifier: PMDA approval for commercial manufacturing
  • FDA · Identifier: US Food and Drug Administration
  • EMA · Identifier: European Medicines Agency
  • NMPA · Identifier: National Medical Products Administration
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.